Gene Query: CENPO

Dataset Description Geneva Score
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 34.46
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 32.93
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 30.86
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 28.56
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 26.94
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 26.93
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 26.24
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 26.18
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 25.75
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 25.38
RNA-seq analysis of uveal melanoma cells treated with FR900359 23.79
Genome-wide transcriptional response to random aneuploidy in human cells 18.8
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 18.55
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 18.04
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 17.32
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 17.17
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 17.03
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 16.99
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 16.93
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 16.84
Identification of transcription start sites for human A549 cell line using ReCappable-seq 16.3
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 16.05
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 15.65
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 15.31
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 14.93
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 14.89
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 14.89
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 14.67
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 14.65
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 14.59
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 14.47
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 14.27
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 14.0
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 13.94
Identification of global regulators of T-helper cell lineage specification 13.94
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 13.59
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 13.56
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 13.38
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 13.11
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 13.03
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 12.92
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 12.66
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 12.65
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 12.64
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 12.07
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 11.93
Differential gene expression of human melanoma cells [RNA-seq] 11.93
Studying the selectivity of a small molecule Synucleozid on transcriptome 11.88
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.82
MYCi361 regulates MYC target genes 11.77
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 11.76
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 11.67
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 11.55
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 11.2
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.19
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.19
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 11.18
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 11.15
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 11.15
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 11.06
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 11.01
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 10.86
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 10.76
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 10.52
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 10.47
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 10.47
Crizotinib v. DMSO in SW480 cells 10.42
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 10.34
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 10.27
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 10.27
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 10.23
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.18
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.18
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.11
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.04
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 9.97
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 9.92
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 9.91
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 9.84
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 9.8
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 9.8
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.72
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.72
A549 cells and MSR-A549 cells 9.72
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 9.72
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 9.71
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 9.69
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 9.69
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 9.69
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 9.66
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 9.6
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 9.47
Downregulation of DDX5/DDX17 and REST 9.39
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 9.34
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 9.3
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 9.2
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 9.2
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 9.15
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 9.05
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 9.05
IRF2 is a master regulator of human keratinocyte stem cell fate 9.02
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 9.02
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 9.01
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 9.01
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 8.92
Genome-wide analysis of Dengue virus 2 infected cells 8.9
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 8.88
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 8.87
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 8.77
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 8.77
Transcriptome analysis of BAP1 knockout and restoration 8.72
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 8.72
Silencing p300 in MCF7 cells to study expression and alternative splicing 8.71
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 8.69
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 8.68
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 8.64
RNA-seq of shEZH2 cells 8.55
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.53
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.52
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.52
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 8.44
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 8.43
A Unique Epigenomic Landscape Defines Human Erythropoiesis 8.28
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 8.28
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 8.21
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.2
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 8.2
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.18
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 8.15
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 8.15
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 8.13
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 8.13
Effect of CHKA knockdown on C4-2 cell transcriptome 8.13
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 8.09
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.07
NR2F2 study 8.07
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 8.07
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 8.06
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 8.04
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.93
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 7.93
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 7.93
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.91
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 7.88
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.88
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.87
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 7.86
RNA-seq analysis to identify the genes regulated by p53-SET interplay 7.84
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 7.81
FBXW7 modulates stress response by post-translational modification of HSF1 7.8
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 7.8
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.79
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 7.79
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 7.79
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 7.76
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 7.74
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 7.69
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 7.69
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.67
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 7.67
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 7.61
Genetic-to-epigenetic Therapy for Pancreatic Cancer 7.61
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 7.52
Endothelial gene expression analysis 7.52
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 7.44
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.4
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.39
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 7.39
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 7.36
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.35
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 7.31
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.29
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 7.27
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 7.27
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 7.27
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 7.27
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 7.26
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 7.26
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.21
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 7.18
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 7.16
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 7.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.14
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 7.11
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 7.08
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 7.08
Regulation of protein translation during mitosis 7.07
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 7.07
IDH3a KO RNA-seq 7.06
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 7.05
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.0
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.98
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.98
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.93
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 6.92
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.92
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.9
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 6.86
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 6.84
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 6.84
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 6.79
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 6.78
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 6.76
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 6.72
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 6.65
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 6.61
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.61
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.59
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.59
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 6.58
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 6.56
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 6.51
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 6.49
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 6.49
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 6.48
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 6.48
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.47
A code of mono-phosphorylation modulates the function of RB. 6.46
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 6.38
RNA-sequencing in irradiated and normal A549 cells. 6.33
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.32
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.32
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.31
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.3
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.3
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 6.3
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 6.3
Paxillin regulates genomic networks in prostate cancer [PC3] 6.3
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.28
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 6.26
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 6.26
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 6.23
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 6.23
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 6.22
Seletive inhibition of CDK9 in DLBCL cell lines 6.21
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 6.2
RNA-seq of resting and activated CD4+ T cells +-JQ1 6.2
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 6.16
Genome-wide chromatin analysis of Ewing sarcoma 6.1
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 6.1
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 6.07
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.03
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.03
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.02
Chromatin landscape of human visceral and subcutaneous adipocytes 5.99
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.98
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 5.96
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.95
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 5.93
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.91
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.91
Differentially expressed vascular development genes for iPSC-ECs from CDI 5.9
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.88
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.88
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.87
Global gene expression profile of dasatinib-resistant RCH-ACV cells 5.85
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 5.84
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.83
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.8
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.79
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.79
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.79
BCL11B 5.73
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.71
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.71
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.67
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.67
Identification of Sin3B regulated genes during quiescence 5.67
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.66
Transcriptome analysis of Zika infected neural stem cells 5.66
Zika infected neural stem cells 5.66
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 5.66
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.64
Gene induction by the USP6 oncogene in response to interferon 5.64
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 5.62
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 5.61
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 5.61
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 5.6
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.59
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 5.59
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.58
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.53
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.51
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 5.5
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.5
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.48
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.36
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.33
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 5.29
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 5.29
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 5.28
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 5.27
RNA-seq differential expression studies: more sequence, or more replication? 5.25
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.25
Overexpression and knockdown experiment for circCSNK1G3 5.23
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 5.21
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.19
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.16
CSL RNA-Seq on HKC and SCC cell lines 5.14
CSL 5.14
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.13
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 5.13
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 5.13
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 5.13
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.1
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 5.09
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 5.08
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 5.05
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 5.01
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 5.01
UV_24h_GRO-Seq 5.0
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 4.96
Effect of drugs on transcriptomic profiles 4.95
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 4.92
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 4.91
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 4.89
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.87
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 4.87
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.84
Survival of pancreatic cancer cells lacking KRAS function 4.81
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 4.74
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.74
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.7
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.7
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.68
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 4.68
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 4.68
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 4.65
PRDM1 inhibits proliferation of human colon cancer organoids 4.59
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.57
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.55
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.55
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 4.52
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 4.52
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.51
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.46
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 4.43
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 4.42
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 4.42
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 4.41
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.11
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 4.03
RNA-seq analysis of BAP1-depleted uveal melanoma cells 4.02
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.93
Gene expression in GBM with Cav3.2 inhibition 3.91
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.86
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 3.8
Entrectinib Resistance in a Neuroblastoma Xenograft Model 3.8
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.75
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 3.74
FOXP2's impact on the primate transcriptome 3.72
Bone marrow derived human B cells [normal proB] 3.71
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.68
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 3.68
Transcriptome-wide identification of CELF2 functional targets in T cells 3.67
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.58
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 3.57
Gene expression profile in breast cancer cells 3.52
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.52
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 3.44
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.38
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 3.37
High-resolution comparative analysis of great ape genomes 3.28
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.26
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.25
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 3.11
6mer seed toxicity in tumour suppressive microRNAs 3.09
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.04
The MEF2B Regulatory Network - RNA-seq data 3.01
The MEF2B Regulatory Network 3.01
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.0
Exploring ILF2 regulatory genes by next-generation sequencing 2.96
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.91
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.85
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 2.78
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 2.78
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.77
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.77
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.76
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.73
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.69
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 2.67
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.67
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.63
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 2.61
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.61
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 2.58
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.57
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.56
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.56
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.56
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.51
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.48
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.48
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 2.45
4sU-seq of HFF exposed to salt and heat stress 2.44
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.41
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  2.36
Effect of from Human Umbilical Vein Endothelial Cells 2.29
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.29
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.26
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.18
RNA-seq analysis of differentiating human erythroblasts 2.14
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.12
EGR1-controlled transcriptome of T HESCs 2.11
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.09
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.09
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.06
Functional significance of the HIV-1 Tat signature amino acid residues 2.04
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.03
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.91
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.89
O-glcnAc reprograms cellular energetics 1.84
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.73
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.72
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.69
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.68
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.67
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.64
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.63
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.63
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.61
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.6
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.53
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.53
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.52
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.49
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.47
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.37
DRB/GRO-Seq -/+ UV 1.25
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.24
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.16
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.15
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.14
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.12
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.09
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.09
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.05
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.0
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.98
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.98
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.96
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.88
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.88
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.86
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.83
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.77
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.77
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 0.73
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.7
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.7
Proliferation-correlated expression 0.68
RNA-seq analysis upon ARID1B overexpression 0.68
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.68
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.68
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.66
Myc activation coordinates gene transcription and protein translation responses 0.65
Gene expression profile of CRC-derived HILEC 0.63
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.61
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.55
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.51
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.49
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.48
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.48
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.46
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.46
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.46
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.46
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 0.4
Effects of transcription on genome - nuclear lamina interactions 0.39
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.39
RNA-seq melanoma 0.34
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.32
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.32
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.31
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.3
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.29
6mer seed toxicity in viral microRNAs 0.27
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.27
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.22
CDK12 mediated transcriptional regulation in U2OS cells 0.19
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.17
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.16
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.16
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.16
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.15
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.12
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.12
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.12
Function and hormonal regulation of GATA3 in human first trimester placentation 0.11
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.1
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.05
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.05
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.04
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.02
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.01
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation